Method analyses cholesterol distribution on cells

Cholesterol is an essential lipid and is critical for maintaining the integrity of the plasma membrane in every cell in the body. But elevated levels of cholesterol in the blood represent a risk factor for coronary artery disease.

The accessible pool of cholesterol on the plasma membrane is thought to play a role in regulating production of cholesterol by cells and likely plays a role in the ability of cells to unload surplus cholesterol. “Accessible cholesterol” on the surface of cells can be detected with a cholesterol-binding protein from bacteria.

By taking advantage of the bacterial protein, along with NanoSIMS imaging, researchers showed that the accessible pool of cholesterol is not evenly distributed on a cell’s plasma membrane but instead is highly enriched on specialised projections from the plasma membrane called microvilli.

“In the past, other scientists had speculated that microvilli play a role in moving cholesterol into and out of cells,” said the study’s co-author, Dr. Stephen Young, a distinguished professor of medicine and human genetics at the David Geffen School of Medicine at UCLA. “The discovery that ‘accessible cholesterol’ is highly enriched in microvilli lends support to that idea.”

The findings were recently published in the journal Proceedings of the National Academy of Sciences USA.

Dr. Haibo Jiang, a study co-author, noted that NanoSIMS imaging provides unique insights into cholesterol distribution on the plasma membrane and future studies will make it possible to assess mechanisms by which cells dispose of excess cholesterol.

“We would like to gain a better understanding of the mechanisms of cholesterol movement in cells and tissues,” said Jiang, a lecturer from the University of Western Australia’s Centre for Microscopy, Characterisation and Analysis.

“We believe that NanoSIMS imaging could yield new strategies for lowering cholesterol levels in the blood or at least new strategies for optimising the effects of existing cholesterol-lowering drugs.” Added Young: “The plan now is to use NanoSIMS, along with novel biochemical approaches, to investigate cholesterol distribution and movement in multiple cell types.”

Additional UCLA authors included: Cuiewen He, Xuchen Hu, Rachel Jung, Thomas Weston, Norma Sandoval, Peter Tontonoz and Loren Fong. Jiang and Matthew Killburn are from the University of Western Australia. The research was supported by the National Heart, Lung, and Blood Institute.